Abstract

Insulin-degrading enzyme (IDE) is a highly conserved and ubiquitously expressed Zn2+-metallopeptidase that regulates hepatic insulin sensitivity, albeit its regulation in response to the fasting-to-postprandial transition is poorly understood. In this work, we studied the regulation of IDE mRNA and protein levels as well as its proteolytic activity in the liver, skeletal muscle, and kidneys under fasting (18 h) and refeeding (30 min and 3 h) conditions, in mice fed a standard (SD) or high-fat (HFD) diets. In the liver of mice fed an HFD, fasting reduced IDE protein levels (~30%); whereas refeeding increased its activity (~45%) in both mice fed an SD and HFD. Likewise, IDE protein levels were reduced in the skeletal muscle (~30%) of mice fed an HFD during the fasting state. Circulating lactate concentrations directly correlated with hepatic IDE activity and protein levels. Of note, L-lactate in liver lysates augmented IDE activity in a dose-dependent manner. Additionally, IDE protein levels in liver and muscle tissues, but not its activity, inversely correlated (R2 = 0.3734 and 0.2951, respectively; p < 0.01) with a surrogate marker of insulin resistance (HOMA index). Finally, a multivariate analysis suggests that circulating insulin, glucose, non-esterified fatty acids, and lactate levels might be important in regulating IDE in liver and muscle tissues. Our results highlight that the nutritional regulation of IDE in liver and skeletal muscle is more complex than previously expected in mice, and that fasting/refeeding does not strongly influence the regulation of renal IDE.

Highlights

  • In response to fasting, circulating glucagon levels were lower in mice fed an high-fat diet (HFD) compared to control mice (Table 1)

  • These results suggest that metabolites (NEFA, lactate, and glucose) and insulin levels, but not alternative mRNA splicing, influence hepatic Insulin-degrading enzyme (IDE) activity in response to refeeding

  • We showed that HFD feeding led to insulin resistance and glucose intolerance in mice (Appendix A, Figure A1)

Read more

Summary

Introduction

The global epidemics of obesity and type 2 diabetes mellitus (T2DM) are major public health concerns [1]. These overnutrition-related chronic diseases are associated with changes in diet and physical activity. Understanding physiological and pathophysiological metabolic adaptations to either fasting or food consumption are essential to preventing and treating these diseases, while minimizing the side effects caused by chronic overnutrition. The molecular and cellular mechanisms associated with metabolic adaptations to fasting and refeeding remain poorly understood

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call